Literature DB >> 23054835

Development of Purkinje cell degeneration in a knockin mouse model reveals lysosomal involvement in the pathogenesis of SCA6.

Toshinori Unno1, Minoru Wakamori, Masato Koike, Yasuo Uchiyama, Kinya Ishikawa, Hisahiko Kubota, Takashi Yoshida, Hiroko Sasakawa, Christoph Peters, Hidehiro Mizusawa, Kei Watase.   

Abstract

Spinocerebellar ataxia type 6 (SCA6) is a neurodegenerative disease caused by the expansion of a polyglutamine tract in the Ca(v)2.1 voltage-gated calcium channel. To elucidate how the expanded polyglutamine tract in this plasma membrane protein causes the disease, we created a unique knockin mouse model that modestly overexpressed the mutant transcripts under the control of an endogenous promoter (MPI-118Q). MPI-118Q mice faithfully recapitulated many features of SCA6, including selective Purkinje cell degeneration. Surprisingly, analysis of inclusion formation in the mutant Purkinje cells indicated the lysosomal localization of accumulated mutant Ca(v)2.1 channels in the absence of autophagic response. The lack of cathepsin B, a major lysosomal cysteine proteinase, exacerbated the loss of Purkinje cells and was accompanied by an acceleration of inclusion formation in this model. Thus, the pathogenic mechanism of SCA6 involves the endolysosomal degradation pathway, and unique pathological features of this model further illustrate the pivotal role of protein context in the pathogenesis of polyglutamine diseases.

Entities:  

Mesh:

Year:  2012        PMID: 23054835      PMCID: PMC3491452          DOI: 10.1073/pnas.1212786109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

Review 1.  Diseases of unstable repeat expansion: mechanisms and common principles.

Authors:  Jennifer R Gatchel; Huda Y Zoghbi
Journal:  Nat Rev Genet       Date:  2005-10       Impact factor: 53.242

Review 2.  Trinucleotide repeat disorders.

Authors:  Harry T Orr; Huda Y Zoghbi
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

3.  Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6.

Authors:  K Ishikawa; H Fujigasaki; H Saegusa; K Ohwada; T Fujita; H Iwamoto; Y Komatsuzaki; S Toru; H Toriyama; M Watanabe; N Ohkoshi; S Shoji; I Kanazawa; T Tanabe; H Mizusawa
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

4.  ORL1 receptor-mediated internalization of N-type calcium channels.

Authors:  Christophe Altier; Houman Khosravani; Rhian M Evans; Shahid Hameed; Jean B Peloquin; Brian A Vartian; Lina Chen; Aaron M Beedle; Stephen S G Ferguson; Alexandre Mezghrani; Stefan J Dubel; Emmanuel Bourinet; John E McRory; Gerald W Zamponi
Journal:  Nat Neurosci       Date:  2005-11-27       Impact factor: 24.884

5.  Degeneration of the inferior olive in spinocerebellar ataxia 6 may depend on disease duration: report of two autopsy cases and statistical analysis of autopsy cases reported to date.

Authors:  Kuniaki Tsuchiya; Tatsuro Oda; Mari Yoshida; Hidenao Sasaki; Chie Haga; Hidemaro Okino; Itaru Tominaga; Kenichi Matsui; Haruhiko Akiyama; Yoshio Hashizume
Journal:  Neuropathology       Date:  2005-06       Impact factor: 1.906

6.  Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice.

Authors:  I A Klement; P J Skinner; M D Kaytor; H Yi; S M Hersch; H B Clark; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

7.  Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.

Authors:  Kei Watase; Curtis F Barrett; Taisuke Miyazaki; Taro Ishiguro; Kinya Ishikawa; Yuanxin Hu; Toshinori Unno; Yaling Sun; Sayumi Kasai; Masahiko Watanabe; Christopher M Gomez; Hidehiro Mizusawa; Richard W Tsien; Huda Y Zoghbi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-07       Impact factor: 11.205

8.  Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

Authors:  F Saudou; S Finkbeiner; D Devys; M E Greenberg
Journal:  Cell       Date:  1998-10-02       Impact factor: 41.582

9.  Ataxia with loss of Purkinje cells in a mouse model for Refsum disease.

Authors:  Sacha Ferdinandusse; Anna W M Zomer; Jasper C Komen; Christina E van den Brink; Melissa Thanos; Frank P T Hamers; Ronald J A Wanders; Paul T van der Saag; Bwee Tien Poll-The; Pedro Brites
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-11       Impact factor: 11.205

10.  A block of autophagy in lysosomal storage disorders.

Authors:  Carmine Settembre; Alessandro Fraldi; Luca Jahreiss; Carmine Spampanato; Consuelo Venturi; Diego Medina; Raquel de Pablo; Carlo Tacchetti; David C Rubinsztein; Andrea Ballabio
Journal:  Hum Mol Genet       Date:  2007-10-03       Impact factor: 6.150

View more
  23 in total

1.  Progression of Dysphagia in Spinocerebellar Ataxia Type 6.

Authors:  Chiharu Isono; Makito Hirano; Hikaru Sakamoto; Shuichi Ueno; Susumu Kusunoki; Yusaku Nakamura
Journal:  Dysphagia       Date:  2017-01-02       Impact factor: 3.438

2.  A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases.

Authors:  Kyota Fujita; Yoko Nakamura; Tsutomu Oka; Hikaru Ito; Takuya Tamura; Kazuhiko Tagawa; Toshikazu Sasabe; Asuka Katsuta; Kazumi Motoki; Hiroki Shiwaku; Masaki Sone; Chisato Yoshida; Masahisa Katsuno; Yoshinobu Eishi; Miho Murata; J Paul Taylor; Erich E Wanker; Kazuteru Kono; Satoshi Tashiro; Gen Sobue; Albert R La Spada; Hitoshi Okazawa
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.

Authors:  Carlo Bavassano; Andreas Eigentler; Ruslan Stanika; Gerald J Obermair; Sylvia Boesch; Georg Dechant; Roxana Nat
Journal:  Stem Cells Dev       Date:  2017-10-30       Impact factor: 3.272

4.  Transient cerebellar alterations during development prior to obvious motor phenotype in a mouse model of spinocerebellar ataxia type 6.

Authors:  Sriram Jayabal; Lovisa Ljungberg; Alanna J Watt
Journal:  J Physiol       Date:  2016-10-02       Impact factor: 5.182

Review 5.  Autophagy in polyglutamine disease: Imposing order on disorder or contributing to the chaos?

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Mol Cell Neurosci       Date:  2015-03-11       Impact factor: 4.314

6.  Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.

Authors:  Jan Cendelin; Marija Cvetanovic; Mandi Gandelman; Hirokazu Hirai; Harry T Orr; Stefan M Pulst; Michael Strupp; Filip Tichanek; Jan Tuma; Mario Manto
Journal:  Cerebellum       Date:  2021-08-10       Impact factor: 3.648

Review 7.  Polyglutamine spinocerebellar ataxias - from genes to potential treatments.

Authors:  Henry L Paulson; Vikram G Shakkottai; H Brent Clark; Harry T Orr
Journal:  Nat Rev Neurosci       Date:  2017-08-17       Impact factor: 34.870

8.  The proteasome regulator PI31 is required for protein homeostasis, synapse maintenance, and neuronal survival in mice.

Authors:  Adi Minis; Jose A Rodriguez; Avi Levin; Kai Liu; Eve-Ellen Govek; Mary E Hatten; Hermann Steller
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-21       Impact factor: 11.205

9.  Pathogenesis of severe ataxia and tremor without the typical signs of neurodegeneration.

Authors:  Joshua J White; Marife Arancillo; Annesha King; Tao Lin; Lauren N Miterko; Samrawit A Gebre; Roy V Sillitoe
Journal:  Neurobiol Dis       Date:  2015-11-14       Impact factor: 5.996

10.  DnaJ-1 and karyopherin α3 suppress degeneration in a new Drosophila model of Spinocerebellar Ataxia Type 6.

Authors:  Wei-Ling Tsou; Ryan R Hosking; Aaron A Burr; Joanna R Sutton; Michelle Ouyang; Xiaofei Du; Christopher M Gomez; Sokol V Todi
Journal:  Hum Mol Genet       Date:  2015-05-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.